Mingzi Tan

794 total citations
28 papers, 615 citations indexed

About

Mingzi Tan is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Mingzi Tan has authored 28 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Reproductive Medicine. Recurrent topics in Mingzi Tan's work include Ovarian cancer diagnosis and treatment (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Autophagy in Disease and Therapy (3 papers). Mingzi Tan is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Autophagy in Disease and Therapy (3 papers). Mingzi Tan collaborates with scholars based in China, United States and Germany. Mingzi Tan's co-authors include Bei Lin, Juanjuan Liu, Liancheng Zhu, Zhenhua Hu, Jian Gao, Huiyu Zhuang, Dawo Liu, Mingbo Cai, Yingying Hao and Huimin Wang and has published in prestigious journals such as International Journal of Molecular Sciences, BMJ and Molecular Cancer.

In The Last Decade

Mingzi Tan

27 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingzi Tan China 16 339 176 160 145 125 28 615
Shogo Shigeta Japan 15 240 0.7× 130 0.7× 45 0.3× 137 0.9× 111 0.9× 50 525
Phil Rolland United Kingdom 10 190 0.6× 88 0.5× 170 1.1× 144 1.0× 229 1.8× 11 582
Sundersingh Shirley India 8 246 0.7× 115 0.7× 59 0.4× 43 0.3× 116 0.9× 14 430
Satoshi Tsunetoh Japan 15 280 0.8× 159 0.9× 68 0.4× 235 1.6× 243 1.9× 32 715
Satoe Fujiwara Japan 14 279 0.8× 169 1.0× 63 0.4× 210 1.4× 227 1.8× 38 677
Steven W. Remmenga United States 13 347 1.0× 83 0.5× 89 0.6× 82 0.6× 157 1.3× 20 720
Sofia Genta Canada 12 289 0.9× 135 0.8× 170 1.1× 114 0.8× 434 3.5× 36 742
Eleonora Zaccarelli Italy 8 172 0.5× 81 0.5× 58 0.4× 129 0.9× 205 1.6× 13 418
Evangelos Bournakis Greece 15 272 0.8× 153 0.9× 39 0.2× 84 0.6× 267 2.1× 35 621
Sufang Wu China 18 484 1.4× 325 1.8× 116 0.7× 25 0.2× 103 0.8× 39 725

Countries citing papers authored by Mingzi Tan

Since Specialization
Citations

This map shows the geographic impact of Mingzi Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzi Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzi Tan more than expected).

Fields of papers citing papers by Mingzi Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzi Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzi Tan. The network helps show where Mingzi Tan may publish in the future.

Co-authorship network of co-authors of Mingzi Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzi Tan. A scholar is included among the top collaborators of Mingzi Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzi Tan. Mingzi Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Nan, Yuying Fan, Zhan Zhang, et al.. (2025). WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma. Journal of Experimental & Clinical Cancer Research. 44(1). 201–201. 1 indexed citations
3.
Tan, Mingzi, et al.. (2022). A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer. Carcinogenesis. 43(7). 635–646. 1 indexed citations
4.
Zhang, Yuhua, Zhuo Li, & Mingzi Tan. (2021). Association Between Diet Quality and Risk of Ovarian and Endometrial Cancers: A Systematic Review of Epidemiological Studies. Frontiers in Oncology. 11. 659183–659183. 6 indexed citations
5.
6.
Hao, Yingying, Liancheng Zhu, Limei Yan, et al.. (2017). c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis�y expression in response to TGF-β1 in ovarian cancer. Oncology Reports. 38(6). 3355–3366. 15 indexed citations
7.
Cai, Mingbo, Shan Jin, Lu Deng, et al.. (2017). Lewis y antigen promotes p27 degradation by regulating ubiquitin-proteasome activity. Oncotarget. 8(66). 110064–110076. 6 indexed citations
8.
Zhu, Liancheng, Qian Guo, Shan Jin, et al.. (2016). Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells. Oncology Reports. 36(3). 1592–1604. 18 indexed citations
9.
Xiao, Li, Yiping Gao, Mingzi Tan, et al.. (2015). Expression of HE4 in Endometrial Cancer and Its Clinical Significance. BioMed Research International. 2015. 1–8. 32 indexed citations
10.
Hu, Zhenhua, Liancheng Zhu, Jian Gao, et al.. (2015). Expression of FOXP1 in epithelial ovarian cancer (EOC) and its correlation with chemotherapy resistance and prognosis. Tumor Biology. 36(9). 7269–7275. 20 indexed citations
11.
Deng, Lu, Li Xiao, Mingbo Cai, et al.. (2015). Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 96–96. 41 indexed citations
12.
Tan, Mingzi, Liancheng Zhu, Huiyu Zhuang, et al.. (2015). Lewis Y antigen modified CD47 is an independent risk factor for poor prognosis and promotes early ovarian cancer metastasis.. PubMed. 5(9). 2777–87. 28 indexed citations
13.
Hu, Zhenhua, Liancheng Zhu, Mingzi Tan, et al.. (2014). The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer. Biochimie. 109. 42–48. 14 indexed citations
14.
Cai, Mingbo, Zhenhua Hu, Juanjuan Liu, et al.. (2014). Expression of hMOF in different ovarian tissues and its effects on ovarian cancer prognosis. Oncology Reports. 33(2). 685–692. 31 indexed citations
15.
Zhuang, Huiyu, Mingzi Tan, Juanjuan Liu, et al.. (2014). The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them. Tumor Biology. 36(4). 2343–2349. 9 indexed citations
16.
Zhuang, Huiyu, Zhenhua Hu, Mingzi Tan, et al.. (2014). Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells. Biochimie. 105. 91–98. 30 indexed citations
17.
Zhuang, Huiyu, Mingzi Tan, Juanjuan Liu, et al.. (2014). Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells. Molecular Cancer. 13(1). 243–243. 47 indexed citations
18.
Gao, Jian, Zhenhua Hu, Juanjuan Liu, et al.. (2014). Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance. Medical Oncology. 31(5). 920–920. 27 indexed citations
19.
Gao, Jian, Zhenhua Hu, Rui Hou, et al.. (2013). Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers. International Journal of Molecular Sciences. 14(6). 11024–11033. 16 indexed citations
20.
Tan, Mingzi & Gavin Yamey. (2012). Paying the poor. BMJ. 345(jul23 1). e4929–e4929. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shogo Shigeta Breakdown of academic impact, for papers by Phil Rolland Breakdown of academic impact, for papers by Sundersingh Shirley Breakdown of academic impact, for papers by Satoshi Tsunetoh Breakdown of academic impact, for papers by Satoe Fujiwara Breakdown of academic impact, for papers by Steven W. Remmenga Breakdown of academic impact, for papers by Sofia Genta Breakdown of academic impact, for papers by Eleonora Zaccarelli Breakdown of academic impact, for papers by Evangelos Bournakis Breakdown of academic impact, for papers by Sufang Wu
Rankless by CCL
2026